Literature DB >> 21490298

Unique pathway for anandamide synthesis and liver regeneration.

Angelo A Izzo1, Dale G Deutsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21490298      PMCID： PMC3080979          DOI： 10.1073/pnas.1103566108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

Authors:  G Arreaza; W A Devane; R L Omeir; G Sajnani; J Kunz; B F Cravatt; D G Deutsch
Journal:  Neurosci Lett       Date:  1997-09-26       Impact factor: 3.046

Review 2.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

Review 3.  CB2 receptors as new therapeutic targets for liver diseases.

Authors:  S Lotersztajn; F Teixeira-Clerc; B Julien; V Deveaux; Y Ichigotani; S Manin; J Tran-Van-Nhieu; M Karsak; A Zimmer; A Mallat
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

4.  A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice.

Authors:  Claudia Mitchell; Holger Willenbring
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

5.  Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.

Authors:  K Katayama; N Ueda; I Katoh; S Yamamoto
Journal:  Biochim Biophys Acta       Date:  1999-09-22

6.  Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver.

Authors:  Bani Mukhopadhyay; Resat Cinar; Shi Yin; Jie Liu; Joseph Tam; Grzegorz Godlewski; Judith Harvey-White; Isioma Mordi; Benjamin F Cravatt; Sophie Lotersztajn; Bin Gao; Qiaoping Yuan; Kornel Schuebel; David Goldman; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

Review 7.  Targeting the endocannabinoid system: to enhance or reduce?

Authors:  Vincenzo Di Marzo
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 8.  Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Authors:  Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

9.  Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2008-01-27       Impact factor: 5.157

Review 10.  Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects.

Authors:  A A Izzo; M Camilleri
Journal:  Gut       Date:  2008-04-08       Impact factor: 23.059
View more
  8 in total

1.  A case series of the dynamics of lipid mediators in patients with sepsis.

Authors:  Mitsuhide Hamaguchi; Heng Ning Wu; Masahiro Tanaka; Noriko Tsuda; Ourlad Alzeus Gaddi Tantengco; Tomohide Matsushima; Takami Nakao; Takuya Ishibe; Ikuhiro Sakata; Itaru Yanagihara
Journal:  Acute Med Surg       Date:  2019-07-18

2.  A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs).

Authors:  Dale G Deutsch
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

Review 3.  Integrating Endocannabinoid Signalling In Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Vineet Mehta; Sukhbir Singh; Ravinder Kumar; Simona Bungau
Journal:  J Mol Neurosci       Date:  2021-01-20       Impact factor: 3.444

Review 4.  Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review.

Authors:  Marta Bryk; Katarzyna Starowicz
Journal:  Pharmacol Rep       Date:  2021-05-28       Impact factor: 3.024

Review 5.  Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases.

Authors:  Thomas Sonnweber; Alex Pizzini; Manfred Nairz; Günter Weiss; Ivan Tancevski
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 5.923

Review 6.  Synopsis of arachidonic acid metabolism: A review.

Authors:  Violette Said Hanna; Ebtisam Abdel Aziz Hafez
Journal:  J Adv Res       Date:  2018-03-13       Impact factor: 10.479

Review 7.  Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis.

Authors:  Pedro Melgar-Lesmes; Meritxell Perramon; Wladimiro Jiménez
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 8.  Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.

Authors:  Tapan Behl; Gagandeep Kaur; Simona Bungau; Rishabh Jhanji; Arun Kumar; Vineet Mehta; Gokhan Zengin; Roxana Brata; Syed Shams Ul Hassan; Ovidiu Fratila
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.